Liver-directed gene transfer in non-human primates

Human Gene Therapy

Volumn 8, Issue 10, 1997, Pages 1195-1206

  Sullivan, Deborah E ^a   Dash, Srikanta ^a   Du, Hong ^a   Hiramatsu, Naoki ^a   Aydin, Faruk ^a   Kolls, Jay ^b   Blanchard, James ^c   Baskin, Gary ^c   Gerber, Michael A ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

^c TULANE NATIONAL PRIMATE RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; NEUTRALIZING ANTIBODY;

ACUTE HEPATITIS; ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL GENE; BILE DUCT; CLONING VECTOR; ESCHERICHIA COLI; GENE THERAPY; GENE TRANSFER; HEPATITIS; IMMUNE RESPONSE; LIVER; LYMPHOCYTE PROLIFERATION; MONKEY; NONHUMAN; PLASMID; PORTAL VEIN; REPORTER GENE; RHESUS MONKEY; SAPHENOUS VEIN; TARGET ORGAN;

ADENOVIRIDAE; ANIMALIA; BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; MACACA MULATTA; PRIMATES;

EID: 0030855887     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1997.8.10-1195     Document Type: Article

References (36)

1. ALT, M., and CASELMANN, W.H. (1995). Liver-directed gene therapy: molecular tools and current preclinical and clinical studies. J. Hepatol. 23, 746-758.
2. ANONYMOUS. (1994). Current Protocols in Immunology. J.E. Coligan, A.M. Kruisbeek, E.M. Marguiles, E.M. Shevach, and W. Strober, eds. (John Wiley & Sons, New York).
3. BRIGHAM, K.L., MEYRICK, B., CHRISTMAN, B., MAGNUSON, M., KING, G., and BERRY, L.C. (1989). In vivo transfection of murine lungs with a functioning prokaryotic gene using a liposome vehicle. Am. J. Med. Sci. 298, 278-281.
4. BRODY, S.L., and CRYSTAL, R.G. (1994). Adenovirus-mediated in vivo gene transfer. Ann. N.Y. Acad. Sci. 716, 90-101.
5. CURIEL, D.T., PILEWSKI, J.M., and ALBELDA, S.M. (1996). Gene therapy approaches for inherited and acquired lung diseases. Am. J. Respir. Cell Mol. Biol. 14, 1-18.
6. DAI, Y., SCHWARZ, E.M., GU, D., ZHANG, W-W., SARVETNICK, N., and VERMA, I.M. (1995). Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: Tolerization of factor IX and vector antigens allows for long-term expression. Proc. Natl. Acad. Sci. USA 92, 1401-1405.
7. ENGLEHARDT, J.F., LITZKY, L., and WILSON, J.M. (1994a). Prolonged transgene expression in cotton rat lung with recombinant adenoviruses defective in E2a. Hum. Gene Ther. 5, 1217-1229.
8. ENGLEHARDT, J.F., YE, X., DORANZ, B., and WILSON, J.M. (1994b). Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory responses in mouse liver. Proc. Natl. Acad. Sci. USA 91, 6196-6200.
9. FANG, B., EISENSMITH, R.C., WANG, H., KAY, M.A., CROSS, R.E., LANDEN, C.N., GORDON, G., BELLINGER, D.A., READ, M.S., HU, P.C., BRINKHOUS, K.M., and WOO, S.L.C. (1995). Gene therapy for hemophilia B: Host immunosuppression prolongs that therapeutic effect of adenovirus-mediated factor IX expression. Hum. Gene Ther. 6, 1039-1044.
10. FELGNER, P.L., TSAI, Y.J., SUKHU, L., WHEELER, C.J., MANTHORPE, M., MARSHALL, J., and CHENG, S.H. (1995). Improved cationic lipid formulations for in vivo gene therapy. Ann. N.Y. Acad. Sci. 772, 126-139.
11. GOLDMAN, M.J., LITZKY, L.A., ENGLEHARDT, J.F., and WILSON, J.M. (1995). Transfer of the CFTR gene to the lung of nonhuman primates with E1-deleted, E2a-defective recombinant adenoviruses: A preclinical toxicology study. Hum. Gene Ther. 6, 839-851.
12. GROSSMAN, M., RAPER, S.E., KOZARSKY, K., STEIN, E.A., ENGELHARDT, J.F., MULLER, D., LUPIEN, P.J., and WILSON, J.M. (1994). Successful ex vivo gene therapy directed to liver in a patient with familial hypercholesterolemia. Nature Genet. 6, 335-341.
13. HERZ, J., and GERARD, R.D. (1993). Adenovirus-mediated transfer of low density lipoprotein receptor gene acutely accelerates cholesterol clearance in normal mice. Proc. Natl. Acad. Sci. USA 90, 2812-2816.
14. IMLER, J.-L., BOUT, A., DREYER, A., DIETERLE, A., SCHULTZ, H., VALERIO, D., MEHTALI, M., and PAVIRANI, A. (1995). Trans-complementation of E1-deleted adenovirus: A new vector to reduce the possibility of codissemination of wild-type and recombinant adenoviruses. Hum. Gene Ther. 6, 711-721.
15. JAFFE, H.A., DANIER, D., LONGENECKER, M., METZGER, M., SETOGUCHI, Y., ROSENFELD, M.A., GANT, T.W., THORGEIRSSON, S.S., STRATFORD-PERRICAUDET, L.D., PERRICAUDET, M., PAVIRANI, A., LECOCQ, J.P., and CRYSTAL, R.G. (1992). Adenovirus-mediated in vivo gene transfer and expression in normal rat liver. Nature Genet. 1, 372-378.
16. KOLLS, J., PEPPER, K., SILVA, M., and BEUTLER, B. (1994). Prolonged and effective blockade of tumor necrosis factor activity through adenovirus-mediated gene transfer. Proc. Natl. Acad. Sci. USA 91, 215-219.
17. KOLLS, J.K., LEI, D., ODOM, G., NELSON, S., SUMMER, W.R., GERBER, M.A., and SHELLITO, J.E. (1996). Use of transient CD4-lymphocyte depletion to prolong transgene expression of E1-deleted adenoviral vectors. Hum. Gene Ther. 7, 489-497.
18. KOZARSKY, K.F., MCKINLEY, D.R., AUSTIN, L.L., RAPER, S.E., STRATFORD-PERRICAUDET, L.D., and WILSON, J.M. (1994). In vivo correction of low density lipoprotein receptor deficiency in the Wantanabe heritable hyperlipidemic rabbit with recombinant adenoviruses. J. Biol. Chem. 269, 13695-13702.
19. LEI, D., WU, J., SULLIVAN, D.E., DASH, S., and GERBER, M.A. (1995). Detection of hepatitis B virus sequences in liver tissues of seronegative organ donors. Int. Hepatol. Commun. 3, 154-160.
20. LI, Q., KAY, M.A., FIENGOLD, M., STRATFORD-PERRICAUDET, L.D., and WOO, S.L.C. (1993). Assessment of recombinant adenoviral vectors for hepatic gene therapy. Hum. Gene Ther. 4, 403-409.
21. LIEBER, A., HE, C-Y., KIRILLOVA, I., and KAY, M.A. (1996). Recombinant adenoviruses with large deletions generated by cre-mediated excision exhibit different biological properties compared with first-generation vectors in vitro and in vivo. J. Virol. 70, 8944-8960.
22. MORRIS, B.D. JR., DRAZAN, K.E., CSETE, M.E., WERTHMAN, P.E., VAN BREE, M.P., ROSENTHAL, J.T., and SHARED, A. (1994). Adenoviral-mediated gene transfer to bladder in vivo. J. Urol. 152, 506-509.
23. MOULLIER, P., FRIEDLANDER, G., CALISE, D., RONCO, P., PERRICAUDET, M. and FERRY, N. (1994). Adenoviral-mediated gene transfer to renal tubular cells in vivo. Kidney Int. 45, 1220-1225.
24. MULLIGAN, R.C. (1993). The basic science of gene therapy. Science 260, 926-932.
25. NUNES, F.A., RAPER, S.E., and WILSON, J.M. (1995). Gene transfer to primate liver using second generation recombinant adenovirus. Gastroenterology 108, A1135.
26. SIMON, R.H., ENGELHARDT, J.F., YANG, Y., ZEPEDA, M., WEBER-PENDLETON, S., GROSSMAN, M., and WILSON, J.M. (1993). Adenovirus-mediated transfer of the CFTR gene to lung of nonhuman primates: Toxicity study. Hum. Gene Ther. 4, 771-780.
27. TAKEHARA, T., HAYASHI, N., MIYAMOTO, Y., YAMAMOTO, M., MITA, E., FUSAMOTO, H., and KAMADA, T. (1995). Expression of the hepatitis C virus genome in rat liver after cationic liposome-mediated in vivo gene transfer. Hepatology 21, 746-51.
28. TEVETHIA, M.J., and SPECTOR, D.J. (1987). Complementation of an adenovirus 5 immediate early mutant by human cytomegalovirus. Virology 137, 428-431.
29. WILSON, J.M. (1996). Molecular medicine: adenoviruses as gene-delivery vehicles. Mol. Med. 334, 1185-1187.
30. WILSON, J.M., GROSSMAN, M., RAPER, S.E., BAKER, J.R., NEWMAN, R.S., and THOEN, J. (1992). Clinical protocol: Ex vivo gene therapy of familial hypercholesterolemia. Hum. Gene Ther. 3, 179-187.
31. YANG, Y., RAPER, S.E., COHN, J.A., ENGELHARDT, J.F., and WILSON, J.M. (1993). An approach for treating the hepatobiliary disease of cystic fibrosis by somatic gene transfer. Proc. Natl. Acad. Sci. USA 90, 4601-1605.
32. YANG, Y., NUNES, F.A., BERENCSI, K., FURTH, E.E., GONCZOL, E., and WILSON, J.M. (1994). Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc. Natl. Acad. Sci. USA 91, 4407-4411.
33. YANG, Y., LI, Q., ERTL, H.C.J., and WILSON, J.M. (1995). Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J. Virol. 69, 2004-2015.
34. YE, X.H., ROBINSON, M.B., BATSHAW, M.L., FURTH, E.E., SMITH, I., and WILSON, J.M. (1996). Prolonged metabolic correction in adult ornithine transcarbamylase-deficient mice with adenoviral vectors. J. Biol. Chem. 271, 3639-3646.
35. ZHANG, W-W., KOCH, P.E., and ROTH, J.A. (1995). Detection of wild-type contamination in a recombinant adenoviral preparation by PCR. Biotechniques 18, 444-447.
36. ZHU, N., LIGGITT, D., LIU, Y., and DEBS, R. (1993). Systemic gene expression after intravenous DNA delivery into adult mice. Science 261, 209-211.